Inventor · disambiguated record
Lucien Maria Henricus Koymans
Also filed as: DE JONGE MARC RENE · JANSSEN LEGAL REPRESENTATIVE M · KOYMANS LUCIEN M H · KOYMANS LUCIEN MARIA HENRICUS
33 granted patents·5 pending applications·743 citations·filing 1999–2019
97Inventor score
Files withJANSSEN PHARMACEUTICA NV23CORTE BART DE2GUILLEMONT JEROME EMILE GEORGES2HEERES JAN2JANSSEN PHARMACEUTICA INC2
Top patents by PatentIndex Score
38 records- 0196US7125879B2HIV inhibiting pyrimidines derivativesJANSSEN PHARMACEUTICA NV·Filed 2002·Granted Oct 24, 2006·96 cites·19 claims
- 0296US6197779B1HIV inhibiting pyrimidine derivativeJANSSEN PHARMACEUTICA INC·Filed 1999·Granted Mar 6, 2001·177 cites·4 claims
- 0395US7514445B2Heteroaryl amines as glycogen synthase kinase 3β inhibitors (GSK3 inhibitors)JANSSEN PHARMACEUTICA NV·Filed 2002·Granted Apr 7, 2009·117 cites·8 claims
- 0495US6440986B2HIV Inhibiting pyrimidine derivativesJANSSEN PHARMACEUTICA NV·Filed 2000·Granted Aug 27, 2002·74 cites·9 claims
- 0592US10611732B2HIV replication inhibiting pyrimidinesJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Apr 7, 2020·3 cites·7 claims
- 0691US7923554B2HIV inhibiting 1,2,4-triazin-6-one derivativesJANSSEN PHARMACEUTICA NV·Filed 2005·Granted Apr 12, 2011·26 cites·25 claims
- 0791US7037917B2HIV replication inhibiting pyrimidinesJANSSEN PHARMACEUTICA NV·Filed 2003·Granted May 2, 2006·34 cites·32 claims
- 0889US8003789B2HIV replication inhibiting pyrimidinesJANSSEN PHARMACEUTICA NV·Filed 2007·Granted Aug 23, 2011·12 cites·19 claims
- 0987US6150360ATrisubstituted 1,3,5-Triazine DerivativesJANSSEN PHARMACEUTICA NV·Filed 1999·Granted Nov 21, 2000·62 cites·16 claims
- 1086US8080551B2HIV inhibiting pyrimidines derivativesGUILLEMONT JEROME EMILE GEORGES·Filed 2006·Granted Dec 20, 2011·8 cites·39 claims
- 1185US7276510B2HIV replication inhibitorsJANSSEN PHARMACEUTICA INC·Filed 2001·Granted Oct 2, 2007·27 cites·49 claims
- 1284US7034019B2Prodrugs of HIV replication inhibiting pyrimidinesJANSSEN PHARMACEUTICA NV·Filed 2001·Granted Apr 25, 2006·14 cites·121 claims
- 1383US9981919B2HIV replication inhibiting pyrimidinesJANSSEN PHARMACEUTICA NV·Filed 2017·Granted May 29, 2018·2 cites·7 claims
- 1483US8828982B2Pyrimidine derivatives for the prevention of HIV infectionHEERES JAN·Filed 2009·Granted Sep 9, 2014·5 cites·18 claims
- 1583US8530655B2HIV replication inhibiting pyrimidinesCORTE BART DE·Filed 2011·Granted Sep 10, 2013·8 cites·10 claims
- 1682US8026248B2HIV inhibiting pyrimidine derivativesJANSSEN PHARMACEUTICA NV·Filed 2005·Granted Sep 27, 2011·4 cites·18 claims
- 1781US6878717B2HIV replication inhibiting pyrimidinesFiled 1999·Granted Apr 12, 2005·37 cites·5 claims
- 1879US9580392B2HIV replication inhibiting pyrimidinesJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Feb 28, 2017·2 cites·8 claims
- 1979US7442705B2HIV replication inhibiting pyrimidines and triazinesTIBOTEC PHARM LTD·Filed 2004·Granted Oct 28, 2008·12 cites·11 claims
- 2076US6774235B2Trisubstituted 1,3,5-triazine derivativesJANSSEN PHARMACEUTICA NV·Filed 2002·Granted Aug 10, 2004·7 cites·1 claims
- 2175US7763631B2Prodrugs of HIV replication inhibiting pyrimidinesJANSSEN PHARMACEUTICA NV·Filed 2005·Granted Jul 27, 2010·2 cites·78 claims
- 2273US6372729B1Trisubstituted 1,3,5,-triazine derivativesJANSSEN PHARMACEUTICA NV·Filed 2000·Granted Apr 16, 2002·5 cites·6 claims
- 2370US7585870B2HIV replication inhibiting pyrimidines and triazinesTIBOTEC BVBA·Filed 2004·Granted Sep 8, 2009·4 cites·11 claims
- 2469US6903213B2HIV inhibiting pyrimidine derivativesFiled 2002·Granted Jun 7, 2005·3 cites·1 claims
- 2567US10370340B2HIV replication inhibiting pyrimidinesJANSSEN PHARMACEUTICA NV·Filed 2018·Granted Aug 6, 2019·0 cites·8 claims
- 2662US2017121292A1Hiv replication inhibiting pyrimidinesJANSSEN PHARMACEUTICA NV·Filed 2017·Application pending·0 cites
- 2757US2012076835A1Hiv inhibiting pyrimidines derivativesGUILLEMONT JEROME EMILE GEORGES·Filed 2011·Application pending·0 cites
- 2854US2005288278A1HIV replication inhibiting pyrimidinesCORTE BART DE·Filed 2005·Application pending·0 cites
- 2952US8378085B2Bacterial ATP synthase binding domainJANSSEN PHARMACEUTICA NV·Filed 2011·Granted Feb 19, 2013·0 cites·5 claims
- 3051US7015221B22,4-disubstituted triazine derivativesJANSSEN PHARMACEUTICA NV·Filed 2003·Granted Mar 21, 2006·0 cites·10 claims
- 3147US8088891B2Bacterial ATP synthase binding domainANDRIES KOENRAAD JOZEF LODEWIJK MARCEL·Filed 2005·Granted Jan 3, 2012·0 cites·10 claims
- 3245US7585861B2HIV inhibiting 1,2,4-triazinesJANSSEN PHARMACEUTICA NV·Filed 2004·Granted Sep 8, 2009·0 cites·19 claims
- 3345US2007021449A1Pyrimidine derivatives for the prevention of hiv infectionHEERES JAN·Filed 2004·Application pending·0 cites
- 3442US8026245B2HIV replication inhibiting purine derivativesJANSSEN PHARMACEUTICA NV·Filed 2004·Granted Sep 27, 2011·0 cites·21 claims
- 3540US7105522B2HIV inhibiting pyrazinone derivativesJANSSEN PHARMACEUTICA NV·Filed 2002·Granted Sep 12, 2006·0 cites·23 claims
- 3639US7183288B2Amide derivatives as glycogen synthase kinase 3-β inhibitorsFREYNE EDDY JEAN EDGARD·Filed 2002·Granted Feb 27, 2007·0 cites·13 claims
- 3738US6638932B12,4-disubstituted triazine derivativesJANSSEN PHARMACEUTICA NV·Filed 1999·Granted Oct 28, 2003·2 cites·11 claims
- 3838US2006063789A1Aminobenzamide derivatives as glycogen synthase kinase 3 beta inhibitorsFREYNE EDDY JEAN E·Filed 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Lucien Maria Henricus Koymans files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →